Hybio Pharmaceutical (300199) — Cash Flow-to-Debt Ratio
Hybio Pharmaceutical (300199) has a Cash Flow-to-Debt Ratio of 0.05x as of September 2025, meaning its operating cash flow of CN¥117.78 Million could theoretically repay 0% of its total liabilities (CN¥2.50 Billion) in one year. See Hybio Pharmaceutical free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Hybio Pharmaceutical Cash Flow-to-Debt Ratio (2007–2024)
Historical debt coverage capacity for Hybio Pharmaceutical across 18 annual periods. For the full cash flow conversion analysis, see Hybio Pharmaceutical operating cash flow efficiency.
Annual Cash Flow-to-Debt Ratio for Hybio Pharmaceutical (2007–2024)
Year-by-year debt coverage analysis for Hybio Pharmaceutical. Check Hybio Pharmaceutical (300199) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.07x | CN¥164.71 Million | CN¥2.41 Billion | ▲ +4917.1% |
| 2023 | 0.00x | CN¥-3.54 Million | CN¥2.49 Billion | ▼ -120.8% |
| 2022 | 0.01x | CN¥15.81 Million | CN¥2.31 Billion | ▼ -90.2% |
| 2021 | 0.07x | CN¥156.83 Million | CN¥2.26 Billion | ▲ +238.9% |
| 2020 | 0.02x | CN¥47.99 Million | CN¥2.34 Billion | ▼ -51.2% |
| 2019 | 0.04x | CN¥104.64 Million | CN¥2.49 Billion | ▲ +102.7% |
| 2018 | 0.02x | CN¥47.00 Million | CN¥2.27 Billion | ▼ -86.3% |
| 2017 | 0.15x | CN¥213.74 Million | CN¥1.41 Billion | ▼ -56.5% |
| 2016 | 0.35x | CN¥296.41 Million | CN¥852.42 Million | ▲ +127.6% |
| 2015 | 0.15x | CN¥138.84 Million | CN¥908.68 Million | ▼ -60.0% |
| 2014 | 0.38x | CN¥153.43 Million | CN¥401.32 Million | ▼ -59.0% |
| 2013 | 0.93x | CN¥153.48 Million | CN¥164.48 Million | ▲ +15.0% |
| 2012 | 0.81x | CN¥87.19 Million | CN¥107.42 Million | ▼ -33.3% |
| 2011 | 1.22x | CN¥72.48 Million | CN¥59.56 Million | ▼ -28.1% |
| 2010 | 1.69x | CN¥54.69 Million | CN¥32.30 Million | ▲ +255.0% |
| 2009 | 0.48x | CN¥26.11 Million | CN¥54.73 Million | ▼ -61.1% |
| 2008 | 1.23x | CN¥45.75 Million | CN¥37.32 Million | ▼ -76.2% |
| 2007 | 5.14x | CN¥49.04 Million | CN¥9.54 Million | — |